Tag Archives: Rx

The Rx Firm Tax Exodus: Is Something Wrong with the U.S. System?

As I read the latest reports of yet another big US Rx firm, this time AbbVie, trying to pull off a “tax inversion” takeover of the Irish-based Shire, I couldn’t help but wonder, what the heck is going on here? Right now, it feels like most major US corporations, especially pharmas, are literally running away […]
Posted in Deals, Europe, Global, Guest Blog, Legal, Op-Ed, Strategy | Also tagged , , , , , | Leave a comment

2014: End of the Road for the American Rx Salesperson?

2014: End of the Road for the American Rx Salesperson? “The only thing you’ve got in this world is what you can sell.” Willy Loman Death of a Salesman During my years with two major U.S. pharmaceutical companies, some of the most interesting individuals I got to know were field salespersons.  Certainly one of my […]
Posted in Guest Blog, Op-Ed, Sales | Also tagged , , , , , | 16 Comments

Obamacare and U.S. Pharma: Two Months In

U.S. Pharma in the Eye of the Obamacare Storm So, we’ve experienced two months of Obamacare.  How is the U.S. pharmaceutical industry doing with this new program?  I spent two weeks getting the opinions of several Rx representatives on their experience with Obamacare, as well as their thoughts on how it is impacting their marketing, […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , | 1 Comment

The Rx Industry, PBMs, and Obamacare

By Tom Norton A significant, though as yet not fully understood player in the launch of Obamacare is the pharmacy benefit manager (PBM) industry.  This uncertainty, due in part to the current Obamacare IT chaos, has more than a few Rx leaders worrying about how the PBMs tied to insurers in the program will end […]
Posted in Guest Blog, healthcare, Op-Ed | Also tagged , , , , , , , | 2 Comments
  • Categories

  • Meta